Companion Animal Specialty Drugs Market Toward a Striking Valuation of US$ 56,828.56 Million by 2032-FMI Study

The specialised pharmaceuticals for companion animals market size is expected to expand at a moderate rate of 4.21% over the course of the forecast period. The market is anticipated to be valued US$37,624.67 million in 2022. The market for specialised drugs for companion animals is projected to grow to a peak of US$ 56,828.56 million …

Companion Animal Specialty Drugs Market Sets Sights on an Extraordinary Valuation of US$ 56,828.56 Million by 2032-FMI Study

During the forecast period, the specialty medications for companion animals market is anticipated to grow at a moderate rate of 4.21%. In 2022, the market is expected to be worth US$37,624.67 million. By the year 2032, it is expected that the market for specialty medications for companion animals will reach a high of US$ 56,828.56 Million. The …

Companion Animal Specialty Drugs Market is likely to register CAGR of 4.21% through 2032

The global companion animal specialty drugs market is anticipated to reach a valuation of US$ 56,828.56 Million by 2032, with the market growing at an average CAGR of 4.21% from 2022 to 2032. Currently valued at US$ 37,624.67 Million, the companion animal specialty drugs market is driven by the growing adoption of pets and the rising focus …

Companion Animal Specialty Drugs Market 2021 Outlook, Current and Future Industry Landscape Analysis 2031

Future Market Insights, Dubai: As per ESOMAR-certified consulting firm Future Market Insights (FMI), the global companion animal specialty drugs market registered steady year-on-year (YoY) growth at 5.42% CAGR in 2021. Increasing pet adoption is a major factor, fuelling the demand for animal nutrition and behavioral products, thereby accelerating sales. With increasing rate of obesity among the pet, demand for anti-obesity …